Analgesics and Anti-inflammatory Drugs Practice Questions

Q: Monoamine oxidase inhibitors (MAOIs) should not be used concurrently with which of the following analgesics?

Pethidine. **Explanation:** The concurrent use of **Pethidine (Meperidine)** and **Monoamine Oxidase Inhibitors (MAOIs)** is strictly contraindicated due to the risk of a life-threatening drug interaction known as **Serotonin Syndrome** (or hyperpyretic coma). **Why Pethidine is the correct answer:** Pethidine acts as a weak serotonin reuptake inhibitor. MAOIs prevent the breakdown of serotonin. When combined, they cause a massive accumulation of serotonin in the synaptic cleft, leading to two distinct types of reactions: 1. **Excitatory Reaction:** Characterized by hyperpyrexia (high fever), agitation, muscle rigidity, convulsions, and cardiovascular instability. 2. **Depressive Reaction:** Characterized by respiratory depression, hypotension, and coma. **Why other options are incorrect:** * **Morphine:** It is primarily a pure mu-opioid agonist and does not significantly affect serotonin reuptake. It is generally considered safe to use with MAOIs, though caution is advised regarding potential potentiation of sedative effects. * **Pentazocine & Buprenorphine:** These are mixed agonist-antagonists. While they have complex receptor profiles, they do not possess the potent serotonergic activity required to trigger the classic MAOI interaction seen with Pethidine. **High-Yield Clinical Pearls for NEET-PG:** * **The "P" Rule:** Remember **P**ethidine + **P**henelzine (MAOI) = **P**yrexia. * **Metabolite Fact:** Pethidine is metabolized to **Norpethidine**, which is neurotoxic and can cause seizures (especially in renal failure). * **Other Serotonergic Opioids:** Besides Pethidine, **Tramadol**, **Tapentadol**, and **Dextromethorphan** should also be avoided with MAOIs to prevent Serotonin Syndrome. * **Clinical Presentation:** Look for the triad of cognitive changes (confusion), autonomic hyperactivity (tachycardia, diaphoresis), and neuromuscular abnormalities (clonus, tremors).

Q: Which of the following is a feature of a nonselective COX inhibitor but not of a selective COX-2 inhibitor?

Antiplatelet aggregatory effect. The correct answer is **B. Antiplatelet aggregatory effect**. ### **Explanation of the Correct Answer** The fundamental difference between nonselective NSAIDs and selective COX-2 inhibitors lies in their effect on **Thromboxane A2 (TXA2)**. * **Nonselective COX inhibitors** (e.g., Aspirin, Ibuprofen) inhibit **COX-1** in platelets. Since platelets lack a nucleus, they cannot synthesize new enzymes; thus, TXA2 production is inhibited for the life of the platelet (7–10 days). This leads to a potent antiplatelet effect. * **Selective COX-2 inhibitors** (e.g., Celecoxib, Etoricoxib) do not inhibit COX-1. Therefore, they do not affect platelet aggregation. In fact, by inhibiting PGI2 (prostacyclin) in the vascular endothelium without affecting TXA2, they may shift the balance toward a **pro-thrombotic state**, increasing cardiovascular risk. ### **Why Other Options are Incorrect** * **A. Analgesic effect:** Both classes are effective analgesics. Pain and inflammation are primarily mediated by COX-2 at the site of injury. * **C. Renal salt and water retention:** Both COX-1 and COX-2 are constitutively expressed in the kidneys. Inhibiting either can lead to decreased renal blood flow, sodium retention, and edema. * **D. Prolongation of labor:** Prostaglandins (PGE2 and PGF2α) are essential for uterine contractions. Both nonselective and selective inhibitors can delay the onset of labor. ### **High-Yield NEET-PG Pearls** * **Aspirin** is the only NSAID that binds **irreversibly** to the COX enzyme. * **Selective COX-2 inhibitors** are preferred in patients with a high risk of GI ulcers (as they spare the protective COX-1 in the gastric mucosa) but are **contraindicated** in patients with ischemic heart disease. * **Paracetamol (Acetaminophen)** is a poor anti-inflammatory because it is inactivated by peroxides at the site of inflammation.

Q: Tolerance develops to all of the following effects of opioids except?

All of the above. **Explanation:** The development of tolerance is a hallmark of chronic opioid use, but it does not occur uniformly across all physiological systems. Tolerance refers to the need for increasing doses to achieve the same pharmacological effect. **Why "All of the above" is correct:** In pharmacology, opioids follow a specific pattern regarding tolerance. While tolerance develops rapidly to effects like euphoria, sedation, and respiratory depression, there are certain effects to which the body **never** (or very minimally) develops tolerance. These are often referred to as the "Exceptions to Opioid Tolerance." 1. **Constipation (Option A):** Opioids act on $\mu$-receptors in the myenteric plexus, decreasing GI motility. This effect persists indefinitely regardless of the dose or duration of use. 2. **Miosis (Option B):** Pinpoint pupils (due to stimulation of the Edinger-Westphal nucleus) remain a consistent sign of opioid use/overdose because tolerance does not develop to the miotic effect. 3. **Convulsions (Option C):** At high doses (especially with Pethidine due to its metabolite norpethidine), opioids can induce seizures. Tolerance does not develop to this excitatory effect. **Clinical Pearls & High-Yield Facts for NEET-PG:** * **Mnemonic for No Tolerance:** "**M-C-C**" (**M**iosis, **C**onstipation, **C**onvulsions). * **Highest Tolerance:** Develops to Euphoria, Analgesia, Sedation, and Respiratory depression. * **Clinical Significance:** Because tolerance does *not* develop to constipation, patients on long-term opioids (e.g., palliative care) must be started on a prophylactic stimulant laxative. * **Diagnostic Sign:** Miosis is a diagnostic "tell" in the ER for opioid overdose, as it persists even in chronic addicts.

Q: Morphine causes vomiting by acting on which of the following?

Chemoreceptor Trigger Zone (CTZ). **Explanation:** **1. Why Option A is Correct:** Morphine and other opioid analgesics induce nausea and vomiting primarily through the **direct stimulation of the Chemoreceptor Trigger Zone (CTZ)** located in the **area postrema** on the floor of the fourth ventricle. This region is outside the blood-brain barrier, making it highly sensitive to circulating chemicals and drugs. Morphine acts on **mu (μ) and kappa (κ) receptors** in the CTZ, which then sends signals to the vomiting center in the medulla to initiate the emetic reflex. **2. Why Other Options are Incorrect:** * **Option B (Gastric Mucosa):** Unlike NSAIDs, which cause vomiting via direct irritation of the gastric mucosa, morphine actually **delays gastric emptying** and increases sphincter tone. While these peripheral effects can contribute to a feeling of bloating or nausea, they are not the primary mechanism for the acute emetic response. * **Option C & D:** Since the primary mechanism is central (CTZ) rather than peripheral (gastric), these options are incorrect. **3. High-Yield Clinical Pearls for NEET-PG:** * **Biphasic Effect:** While low doses of morphine stimulate the CTZ (emetic), very high doses can actually **depress the vomiting center** (anti-emetic). * **Vestibular Component:** Morphine increases the sensitivity of the **vestibular apparatus**. This is why morphine-induced vomiting is more common in ambulatory patients than in those lying still. * **Management:** Opioid-induced vomiting can be managed with dopamine antagonists (like Metoclopramide) or 5-HT3 antagonists (like Ondansetron). * **Tolerance:** Tolerance usually develops to the emetic effects of morphine with chronic use, unlike the miotic (pinpoint pupil) and constipating effects.

Q: Which of the following does not exert an analgesic effect?

Cholinergic antagonists. **Explanation:** The correct answer is **Cholinergic antagonists**. In the context of pain modulation, cholinergic **agonists** (like nicotine or muscarinic agonists) and acetylcholinesterase inhibitors actually enhance analgesia by increasing acetylcholine levels in the spinal cord. Conversely, cholinergic antagonists (like atropine) block these pathways and do not possess analgesic properties; in some experimental models, they may even antagonize the effects of other painkillers. **Analysis of Options:** * **Adrenergic antagonists (B):** While alpha-2 *agonists* (like Clonidine) are well-known analgesics, certain adrenergic antagonists (especially Beta-blockers like Propranolol) are used clinically for the prophylaxis of migraine and can modulate pain perception. * **Morphine (C):** This is the gold-standard opioid analgesic [1], [2]. It acts on μ-opioid receptors in the CNS to inhibit ascending pain pathways and activate descending inhibitory pathways [1], [2]. * **Substance P antagonists (D):** Substance P is a key neuropeptide involved in the transmission of pain signals via NK1 receptors. Antagonists of these receptors (e.g., Aprepitant, though primarily used as an antiemetic) have been extensively studied for their potential to block nociceptive transmission. **High-Yield Clinical Pearls for NEET-PG:** * **Descending Inhibitory Pathway:** This is the body's natural "pain-killer" system. It primarily utilizes **Norepinephrine (NE), Serotonin (5-HT), and Acetylcholine (ACh)**. * **Alpha-2 Agonists:** Dexmedetomidine and Clonidine are frequently used in anesthesia for their potent analgesic and sedative-sparing effects. * **Ziconotide:** A high-yield N-type calcium channel blocker used for refractory chronic pain. * **Nefopam:** A unique non-opioid, non-NSAID central analgesic that acts by inhibiting the reuptake of NE, 5-HT, and Dopamine.

Q: Which of the following drugs does NOT possess anti-inflammatory action?

Paracetamol. **Explanation:** The correct answer is **Paracetamol (Acetaminophen)**. **Mechanism of Action & Why it is Correct:** Paracetamol is a unique non-opioid analgesic. Unlike traditional NSAIDs, it is a **poor inhibitor of cyclooxygenase (COX-1 and COX-2) in peripheral tissues**. Its primary action is the inhibition of prostaglandin synthesis within the **Central Nervous System (CNS)**. In peripheral inflamed tissues, high concentrations of peroxides neutralize the inhibitory effect of paracetamol on COX enzymes. Consequently, while it is highly effective as an **analgesic** and **antipyretic**, it lacks significant **anti-inflammatory** and anti-platelet activity. **Analysis of Incorrect Options:** * **A. Indomethacin:** A potent, non-selective COX inhibitor. It is one of the most powerful anti-inflammatory agents, often used for acute gout and ankylosing spondylitis. * **C. Ketorolac:** A pyrrolo-pyrrole derivative with potent analgesic and moderate anti-inflammatory properties. It is frequently used for post-operative pain management. * **D. Ibuprofen:** A propionic acid derivative that non-selectively inhibits COX-1 and COX-2, providing effective anti-inflammatory action at higher doses. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Paracetamol is the preferred antipyretic in children (to avoid Reye’s syndrome associated with Aspirin) and in patients with peptic ulcer disease. * **Toxicity:** Acute overdose leads to **Centrilobular Hepatic Necrosis** due to the metabolite **NAPQI**. * **Antidote:** **N-acetylcysteine (NAC)**, which replenishes glutathione stores. * **COX-3:** Some literature suggests paracetamol may act on a splice variant of COX-1, often referred to as COX-3, primarily in the brain.

Q: Which of the following is NOT an opioid agonist?

Ketamine. **Explanation:** The correct answer is **Ketamine** because it is a non-opioid anesthetic agent. Its primary mechanism of action is the **non-competitive antagonism of NMDA (N-methyl-D-aspartate) receptors**. While it provides potent analgesia, it does not act as an agonist at the mu, kappa, or delta opioid receptors. **Analysis of Options:** * **Morphine (Option A):** The prototype opioid agonist. It acts primarily on **mu (μ) receptors** to provide analgesia, sedation, and euphoria. * **Codeine (Option B):** A natural opium alkaloid that acts as a weak opioid agonist. It is a prodrug converted to morphine by the enzyme CYP2D6. * **Methadone (Option C):** A synthetic, long-acting **mu-opioid agonist**. It is clinically significant for its use in opioid detoxification and maintenance programs due to its long half-life and minimal withdrawal symptoms. **High-Yield Clinical Pearls for NEET-PG:** * **Ketamine’s Unique Profile:** It causes **"Dissociative Anesthesia"** (patient appears awake but is detached from the environment). Unlike opioids, it stimulates the sympathetic nervous system, causing increased HR, BP, and CO, making it the induction agent of choice in **hypovolemic shock**. * **Side Effects:** Ketamine is associated with **emergence delirium** and hallucinations (minimized by benzodiazepines). * **Opioid Antagonist:** Remember **Naloxone** (short-acting, used for acute toxicity) and **Naltrexone** (long-acting, used for relapse prevention). * **Pure Agonists vs. Mixed:** Pentazocine and Nalbuphine are agonist-antagonists, often tested as distractors in this category.

Q: What is the neurotransmitter secreted by postganglionic sympathetic fibers innervating sweat glands?

Acetylcholine. ### Explanation **Correct Answer: C. Acetylcholine** **Understanding the Concept:** In the Autonomic Nervous System (ANS), the standard rule is that all preganglionic fibers (both sympathetic and parasympathetic) release **Acetylcholine (ACh)**. For postganglionic fibers, the parasympathetic system uses ACh, while the sympathetic system typically uses **Norepinephrine**. However, there is a classic **anatomical exception** to this rule: the sympathetic postganglionic fibers innervating **eccrine sweat glands** (involved in thermoregulation) are **sudomotor cholinergic**. They release Acetylcholine, which acts on **Muscarinic (M3)** receptors. This is a high-yield "exception to the rule" frequently tested in NEET-PG. **Analysis of Incorrect Options:** * **A. Norepinephrine:** This is the primary neurotransmitter for most sympathetic postganglionic junctions (e.g., heart, blood vessels). It is not used for thermoregulatory sweat glands. * **B. Epinephrine:** This is a hormone primarily secreted by the adrenal medulla into the bloodstream, rather than a neurotransmitter released by postganglionic nerve terminals. * **D. Dopamine:** While dopamine is a precursor to norepinephrine and acts as a neurotransmitter in the CNS and renal vascular smooth muscle (D1 receptors), it is not involved in sweat gland innervation. **High-Yield Clinical Pearls for NEET-PG:** * **Exception 1:** Sympathetic postganglionic fibers to **sweat glands** release **ACh**. * **Exception 2:** Sympathetic postganglionic fibers to **renal vascular smooth muscle** release **Dopamine**. * **Exception 3:** The **Adrenal Medulla** is directly innervated by sympathetic *preganglionic* fibers (releasing ACh), making it functionally equivalent to a sympathetic ganglion. * **Clinical Correlation:** Anticholinergic drugs (like Atropine) inhibit sweating, leading to "Atropine fever" or hyperthermia, especially in children.

Q: Which of the following is a common side effect of colchicine?

Diarrhea. **Explanation:** **Colchicine** is a unique anti-inflammatory agent primarily used for the management of acute gouty arthritis and prophylaxis. Its mechanism of action involves binding to tubulin, which inhibits microtubule polymerization [1]. This disrupts leukocyte migration, chemotaxis, and phagocytosis. **Why Diarrhea is the Correct Answer:** The most common and dose-limiting side effect of colchicine is **gastrointestinal distress**, specifically **diarrhea**, nausea, and vomiting [2]. This occurs because colchicine inhibits the rapid turnover of intestinal mucosal cells (which are highly dependent on microtubule-mediated mitosis). Diarrhea often serves as a clinical "stop signal," indicating that the maximum tolerated dose has been reached [2]. **Analysis of Incorrect Options:** * **A. Neutropenia:** While chronic high-dose colchicine can cause bone marrow suppression (leading to agranulocytosis or aplastic anemia), it is a rare, toxic effect rather than a "common" side effect. * **B. Asthma:** Colchicine does not cause bronchospasm or asthma. In fact, drugs like NSAIDs (via leukotriene shunting) are more commonly associated with drug-induced asthma. * **C. Fever:** Fever is not a side effect of colchicine; rather, colchicine is sometimes used to treat Familial Mediterranean Fever (FMF) [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Binds to tubulin $\rightarrow$ inhibits microtubule assembly $\rightarrow$ arrests mitosis in metaphase [1]. * **Drug of Choice:** Colchicine is the drug of choice for **prophylaxis** of gout and for **Familial Mediterranean Fever** [1]. * **Toxicity:** Acute overdose can lead to multi-organ failure. Chronic use may cause **myopathy** and **neuropathy**, especially when combined with statins. * **Contraindication:** It should be avoided in patients with severe renal or hepatic impairment [2].

Question 1

All of the following are true regarding acetaminophen EXCEPT:

Accepted Answer

Approximately 95% of acetaminophen undergoes detoxification by CYP2E1.

Answer

It is the most commonly used analgesic.

Answer

In severe doses, liver failure may occur.

Answer

Injury to the liver is produced by NAPQI.

Question 2

Monoamine oxidase inhibitors (MAOIs) should not be used concurrently with which of the following analgesics?

Accepted Answer

Pethidine

Answer

Pentazocine

Answer

Buprenorphine

Answer

Morphine

Question 3

Which of the following is a feature of a nonselective COX inhibitor but not of a selective COX-2 inhibitor?

Accepted Answer

Antiplatelet aggregatory effect

Answer

Analgesic effect

Answer

Renal salt and water retention

Answer

Prolongation of labor

Question 4

Tolerance develops to all of the following effects of opioids except?

Accepted Answer

All of the above

Answer

Constipation

Answer

Miosis

Answer

Convulsions

Question 5

Morphine causes vomiting by acting on which of the following?

Accepted Answer

Chemoreceptor Trigger Zone (CTZ)

Answer

Gastric mucosa

Answer

Both of the above

Answer

None of the above

Question 6

Which of the following does not exert an analgesic effect?

Accepted Answer

Cholinergic antagonists

Answer

Adrenergic antagonists

Answer

Morphine

Answer

Substance P antagonists

Question 7

Which of the following drugs does NOT possess anti-inflammatory action?

Accepted Answer

Paracetamol

Answer

Indomethacin

Answer

Ketorolac

Answer

Ibuprofen

Question 8

Which of the following is NOT an opioid agonist?

Accepted Answer

Ketamine

Answer

Morphine

Answer

Codeine

Answer

Methadone

Question 9

What is the neurotransmitter secreted by postganglionic sympathetic fibers innervating sweat glands?

Accepted Answer

Acetylcholine

Answer

Norepinephrine

Answer

Epinephrine

Answer

Dopamine

Question 10

Which of the following is a common side effect of colchicine?

Accepted Answer

Diarrhea

Answer

Neutropenia

Answer

Asthma

Answer

Fever

Analgesics and Anti-inflammatory Drugs — MCQs

Analgesics and Anti-inflammatory Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?